D.E. Shaw & Co’s Odonate Therapeutics ODT Stock Holding History
Bought
Maintained
Sold
Other funds holding ODT
D.E. Shaw & Co's ODT Position: Q1 2022 in Review
D.E. Shaw & Co sold out of Odonate Therapeutics (ODT) in Q1 2022, closing a stake of 374,195 shares — an estimated $505K sold.
D.E. Shaw & Co first reported a position in ODT in Q1 2018 and held it in 13 quarters. The position peaked at $4.28M in Q2 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.
- D.E. Shaw & Co reported no remaining Odonate Therapeutics position as of Q1 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 374,195 Odonate Therapeutics shares in Q1 2022, an estimated $505K.
- D.E. Shaw & Co first reported a position in Odonate Therapeutics in Q1 2018 and held it in 13 quarters.
- D.E. Shaw & Co's Odonate Therapeutics position peaked at $4.28M in Q2 2020.
- 8 funds tracked by Wall St. Rank held Odonate Therapeutics as of Q1 2022.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.